Alife Health
Latest round
- Series A
Last raised
- Mar 2022
Total raised
- $32M
Investors
- 6
About Alife Health
Founded in 2020 and based in California, US, Alife Health, Inc. is a fertility technology company that develops and provides AI (artificial intelligence)-based tools for fertility specialists. Founder and CEO Mr. Paxton Maeder-York used to develop surgical robots for lung cancer, is currently focused on integrating artificial intelligence and machine learning into in vitro fertilization (IVF) treatments. The company's development team offers an AI-based operating system that enables fertility specialists to improve the reproductive outcomes of patients suffering from infertility. The platform provides data used to create a personalized treatment for in vitro fertilization (IVF) patients. Alife Health, Inc.
Who invested in Alife Health
6 investors across 2 rounds
See all investors in Alife Health
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Alife Health
Who invested in Alife Health?
Alife Health has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Alife Health raised?
Alife Health has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Alife Health last raise money?
Alife Health's most recent round on record is a Series A, in Mar 2022.
What does Alife Health do?
Founded in 2020 and based in California, US, Alife Health, Inc.
Where is Alife Health headquartered?
Alife Health is headquartered in San Francisco, US.
Which VCs invest in companies like Alife Health?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back software companies at Alife Health's stage. Their profiles are linked below.
VCs backing software startups at Series A
Raising like Alife Health? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.